Clinical Trials
14 trialsNCT07061977 2026-05-26
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
National Cancer Institute (NCI)
Phase 3 Recruiting
NCT05570422 2026-04-08
A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01
Kortuc, Inc.
Phase 1 Recruiting
NCT07276360 2026-03-27
HypoRTCx-UG
Uganda Cancer Institute
Phase 2 Recruiting
NCT06331468 2025-12-26
Hypofractionated Radiochemotherapy
University of Kentucky
Phase 2 Recruiting
NCT03422198 2025-12-12
SAVE
University of Utah
Phase 3 Recruiting
NCT07232654 2025-12-01
Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT06543576 2025-08-15
External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
Jonsson Comprehensive Cancer Center
Phase 1/2 Recruiting
NCT07121543 2025-08-13
Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy
University of California, San Diego
Recruiting
NCT05857631 2025-04-15
PARCERII
Tata Memorial Centre
Phase NA Recruiting
NCT06288373 2024-10-30
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
Tongji Hospital
Phase 2/3 Recruiting
NCT05173272 2023-12-27
Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer
Sichuan Cancer Hospital and Research Institute
Phase 3 Recruiting
NCT05406856 2023-10-11
PROTECT
Leiden University Medical Center
Phase NA Recruiting
NCT05242861 2022-02-16
RetroBT
Zhejiang Cancer Hospital
Recruiting
NCT03249519 2017-08-15
Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer
University of Erlangen-Nürnberg Medical School
Phase NA Recruiting